Clinical Trials Logo
  1. Home
  2. Antiplatelet Therapy
  3. NCT04624295

Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)

Antiplatelet Therapy Clinical Trial

Official title:
Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis in China (HITs)：a Randomized Clinical Trial

Clinical Trial Summary

Previous study showed that the proportions of hemorrhagic Infarction after intravenous thrombolysis were 24.2% and 32.5% in the control group and the alteplase group, and most of them were asymptomatic. Hemorrhagic Infarction was a part of the natural progression after acute ischemic stroke. Previous study have shown no significant relationship between hemorrhagic Infarction and poor outcome in acute ischemic stroke (AIS) patients. In this study, a randomized controlled trial will be conducted to explore the efficacy and safety of early antiplatelet therapy after hemorrhagic infarction in acute ischemic stroke treated with intravenous thrombolysis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04624295
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Min Lou, PhD
Phone +8657187784810
Email loumingxc@vip.sina.com
Status Recruiting
Phase Phase 4
Start date November 1, 2020
Completion date June 30, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01231035 - REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS) N/A
Recruiting NCT03525145 - Platelet Reactivity And Clinical ThrombotIC Events Study
Completed NCT01144819 - Platelet Inhibition in the Acute Phase of STEMI N/A
Completed NCT03039205 - Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor Phase 2
Recruiting NCT05554822 - Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study Phase 3
Recruiting NCT02099422 - Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome N/A
Recruiting NCT03758248 - The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI
Not yet recruiting NCT04060914 - LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention Phase 4
Terminated NCT03224923 - A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY) Phase 4
Completed NCT03987373 - DACAB Trial: Follow-up Extension